Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

NCT00281814

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

NCT02142530

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +27 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

NCT01724021

Conditions: Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Buenos Aires, Argentina

Corrientes, Argentina

Santa Fe, Argentina

Canberra, Australian Capital Territory, Australia

View all 246 locations

View Trial Details

Completed

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

NCT01097057

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

NCT00619645

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +49 more
Locations: University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

NCT00867529

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +83 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's Lymphoma

NCT01684865

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Clinic of Hematology Skopje, Hospital Care Department Skopje, North Macedonia

View Trial Details

Completed

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

NCT01534715

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Ohio State University Columbus, Ohio, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Completed

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

NCT02057445

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkins Lymphoma, +10 more
Locations: Children's National Medical Center Washington D.C., District of Columbia, United States

New York Medical College Valhalla, New York, United States

View Trial Details

Completed

A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00201669

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +12 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions